These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 23726162)

  • 1. The Global Drug Facility and its role in the market for tuberculosis drugs.
    Arinaminpathy N; Cordier-Lassalle T; Vijay A; Dye C
    Lancet; 2013 Oct; 382(9901):1373-9. PubMed ID: 23726162
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Global TB Drug Facility: innovative global procurement.
    Kumaresan J; Smith I; Arnold V; Evans P
    Int J Tuberc Lung Dis; 2004 Jan; 8(1):130-8. PubMed ID: 14974756
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Global Drug Facility: a unique, holistic and pioneering approach to drug procurement and management.
    Matiru R; Ryan T
    Bull World Health Organ; 2007 May; 85(5):348-53. PubMed ID: 17639218
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The procurement landscape of pediatric tuberculosis treatment: a Global Drug Facility perspective.
    Scott C; Gardiner E; de Lucia A
    Int J Tuberc Lung Dis; 2015 Dec; 19 Suppl 1():17-22. PubMed ID: 26564536
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Can Brazil play a more important role in global tuberculosis drug production? An assessment of current capacity and challenges.
    Gemal A; Keravec J; Menezes A; Trajman A
    BMC Public Health; 2013 Mar; 13():279. PubMed ID: 23537151
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Global Drug Facility as an intervention in the market for tuberculosis drugs.
    Arinaminpathy N; Cordier-Lassalle T; Lunte K; Dye C
    Bull World Health Organ; 2015 Apr; 93(4):237-248A. PubMed ID: 26229188
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reducing the price of treatment for multidrug-resistant tuberculosis through the Global Drug Facility.
    Lunte K; Cordier-Lassalle T; Keravec J
    Bull World Health Organ; 2015 Apr; 93(4):279-82. PubMed ID: 26229192
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Financial resources required for tuberculosis control to achieve global targets set for 2015.
    Floyd K; Pantoja A
    Bull World Health Organ; 2008 Jul; 86(7):568-76. PubMed ID: 18670669
    [TBL] [Abstract][Full Text] [Related]  

  • 9. What would it take to eliminate tuberculosis in the Eastern Mediterranean Region? (Editorial).
    Aziz MA; Baghdadi S; Hajjeh R
    East Mediterr Health J; 2017 Aug; 23(6):393-394. PubMed ID: 30378665
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pediatric tuberculosis drug market: an insider perspective on challenges and solutions.
    Usherenko I; Basu Roy U; Mazlish S; Liu S; Benkoscki L; Coutts D; Epstein S; Qian M; Rafiq S; Scott C
    Int J Tuberc Lung Dis; 2015 Dec; 19 Suppl 1():23-31. PubMed ID: 26564537
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fixed-dose combination drugs for tuberculosis: application in standardised treatment regimens.
    Blomberg B; Fourie B
    Drugs; 2003; 63(6):535-53. PubMed ID: 12656652
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tuberculosis drug issues: prices, fixed-dose combination products and second-line drugs.
    Laing RO; McGoldrick KM
    Int J Tuberc Lung Dis; 2000 Dec; 4(12 Suppl 2):S194-207. PubMed ID: 11144553
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Limited access to drugs for resistant tuberculosis: a call to action.
    Bélard S; Janssen S; Osbak KK; Adegnika AA; Ondounda M; Grobusch MP
    J Public Health (Oxf); 2015 Dec; 37(4):691-3. PubMed ID: 25527468
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Scaling up towards international targets for AIDS, tuberculosis, and malaria: contribution of global fund-supported programs in 2011-2015.
    Katz I; Komatsu R; Low-Beer D; Atun R
    PLoS One; 2011 Feb; 6(2):e17166. PubMed ID: 21383839
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The danger of in-kind drug donations to the Global Fund.
    Baker BK; Ombaka E
    Lancet; 2009 Apr; 373(9670):1218-21. PubMed ID: 18848353
    [No Abstract]   [Full Text] [Related]  

  • 16. Estimating the market for tuberculosis drugs in industrialized and developing nations.
    Schwalbe NR; Wells WA; Geaneotes AP; Forcellina A; Lee MG; Dicola L; Ignatius HR; Walker CL; Raafat T; Patel N
    Int J Tuberc Lung Dis; 2008 Oct; 12(10):1173-81. PubMed ID: 18812048
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Slow progress worries Stop TB Partnership.
    Sharma DC
    Lancet Infect Dis; 2004 May; 4(5):256. PubMed ID: 15141696
    [No Abstract]   [Full Text] [Related]  

  • 18. Tuberculosis: a new vision for the 21st century.
    Small PM
    Kekkaku; 2009 Nov; 84(11):721-6. PubMed ID: 19999594
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improve tuberculosis services for HIV patients, says WHO.
    Ashraf H
    Lancet; 2003 Jul; 362(9379):218. PubMed ID: 12885508
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.